BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30097238)

  • 1. Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer.
    Trestini I; Carbognin L; Monteverdi S; Zanelli S; De Toma A; Bonaiuto C; Nortilli R; Fiorio E; Pilotto S; Di Maio M; Gasbarrini A; Scambia G; Tortora G; Bria E
    Crit Rev Oncol Hematol; 2018 Sep; 129():54-66. PubMed ID: 30097238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Body Weight and Body Composition on Ovarian Cancer Prognosis.
    Purcell SA; Elliott SA; Kroenke CH; Sawyer MB; Prado CM
    Curr Oncol Rep; 2016 Feb; 18(2):8. PubMed ID: 26769113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
    Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
    Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant Therapy for HER2-positive Breast Cancer.
    Wuerstlein R; Harbeck N
    Rev Recent Clin Trials; 2017; 12(2):81-92. PubMed ID: 28164759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early breast cancer: why does obesity affect prognosis?
    Heetun A; Cutress RI; Copson ER
    Proc Nutr Soc; 2018 Nov; 77(4):369-381. PubMed ID: 29860965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
    Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
    JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of a lifestyle intervention on body weight and serum biomarkers in breast cancer survivors with overweight and obesity.
    Campbell KL; Van Patten CL; Neil SE; Kirkham AA; Gotay CC; Gelmon KA; McKenzie DC
    J Acad Nutr Diet; 2012 Apr; 112(4):559-67. PubMed ID: 22709706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premature ovarian failure and body composition changes with adjuvant chemotherapy for breast cancer.
    Gordon AM; Hurwitz S; Shapiro CL; LeBoff MS
    Menopause; 2011 Nov; 18(11):1244-8. PubMed ID: 21814159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overweight, obesity and breast cancer prognosis: optimal body size indicator cut-points.
    Majed B; Moreau T; Asselain B;
    Breast Cancer Res Treat; 2009 May; 115(1):193-203. PubMed ID: 18546073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eicosapentaenoic acid in cancer improves body composition and modulates metabolism.
    Pappalardo G; Almeida A; Ravasco P
    Nutrition; 2015 Apr; 31(4):549-55. PubMed ID: 25770317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMI and Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Study and Meta-Analysis.
    Erbes T; Stickeler E; Rücker G; Buroh S; Asberger J; Dany N; Thornton S; Iborra S; Hirschfeld M; Gitsch G; Mayer S
    Clin Breast Cancer; 2016 Aug; 16(4):e119-32. PubMed ID: 27067040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Body Mass Index- and Actual Weight-Based Neoadjuvant Chemotherapy Doses on Pathologic Complete Response in Operable Breast Cancer.
    Raman R; Mott SL; Schroeder MC; Phadke S; El Masri J; Thomas A
    Clin Breast Cancer; 2016 Dec; 16(6):480-486. PubMed ID: 27431461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body weight correlates with mortality in early-stage breast cancer.
    Enger SM; Greif JM; Polikoff J; Press M
    Arch Surg; 2004 Sep; 139(9):954-58; discussion 958-60. PubMed ID: 15381612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and prognosis of breast cancer.
    Carmichael AR
    Obes Rev; 2006 Nov; 7(4):333-40. PubMed ID: 17038127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stoutness and prognosis of female non-metastatic breast cancer: results from a French observational cohort study].
    Majed B; Moreau T; Senouci K; Sigal B; Salmon RJ; Fourquet A; Asselain B
    Bull Cancer; 2009 May; 96(5):531-41. PubMed ID: 19467984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in weight and body composition in women receiving chemotherapy for breast cancer.
    Nissen MJ; Shapiro A; Swenson KK
    Clin Breast Cancer; 2011 Mar; 11(1):52-60. PubMed ID: 21421523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from the neoadjuvant setting on how best to choose adjuvant therapies.
    von Minckwitz G; Loibl S; Maisch A; Untch M
    Breast; 2011 Oct; 20 Suppl 3():S142-5. PubMed ID: 22015282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General and abdominal obesity and survival among young women with breast cancer.
    Abrahamson PE; Gammon MD; Lund MJ; Flagg EW; Porter PL; Stevens J; Swanson CA; Brinton LA; Eley JW; Coates RJ
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1871-7. PubMed ID: 17035393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of body mass index (BMI) on the prognosis of high-risk early breast cancer (EBC) patients treated with adjuvant chemotherapy.
    Gennari A; Amadori D; Scarpi E; Farolfi A; Paradiso A; Mangia A; Biglia N; Gianni L; Tienghi A; Rocca A; Maltoni R; Antonucci G; Bruzzi P; Nanni O
    Breast Cancer Res Treat; 2016 Aug; 159(1):79-86. PubMed ID: 27460638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.